Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Alvarez

Showing results (981-990 of 1,020) with videos related to

Pageof 102
Sort By:
ESMO Open|April 11, 2022
Results from the INMUNOSUN-SOGUG trial: a prospective phase II study of sunitinib as a second-line therapy in patients with metastatic renal cell carcinoma after immune checkpoint-based combination therapyE Grande, T Alonso-Gordoa, O Reig, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 9, 2010
Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE)R Garcia-Carbonero, J Capdevila, G Crespo-Herrero, et al.
Journal of Nutritional Science|October 29, 2019
Association between adiposity levels and cognitive impairment in the Chilean older adult populationY Concha-Cisternas, F Lanuza, H Waddell, et al.
Journal of Medicinal Chemistry|July 20, 1999
Identification of pharmacokinetically stable 3, 10-dibromo-8-chlorobenzocycloheptapyridine farnesyl protein transferase inhibitors with potent enzyme and cellular activitiesA G Taveras, J Deskus, J Chao, et al.
BMC Musculoskeletal Disorders|February 17, 2012
Land- and water-based exercise intervention in women with fibromyalgia: the al-Andalus physical activity randomised controlled trialAna Carbonell-Baeza, Jonatan R Ruiz, Virginia A Aparicio, et al.
Clinical Rheumatology|November 27, 2014
Work disability is related to the presence of arthritis and not to a specific diagnosis. Results from a large early arthritis cohort in ArgentinaGustavo Citera, Hernan Maldonado Ficco, Rodolfo S Pérez Alamino, et al.
Bioorganic & Medicinal Chemistry|January 1, 1997
Antitumor 8-chlorobenzocycloheptapyridines: a new class of selective, nonpeptidic, nonsulfhydryl inhibitors of ras farnesylationA K Mallams, F G Njoroge, R J Doll, et al.
Allergologia Et Immunopathologia|January 1, 2019
Treatment, outcomes and costs of asthma exacerbations in Chilean children: a prospective multicenter observational studyA M Herrera, P Brand, G Cavada, et al.
Revista De Neurologia|February 12, 2011
[Review of the novelties presented at the 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I)]Oscar Fernández-Fernández, José C Alvarez-Cermeño, Txomin Arbizu-Urdiain, et al.
Revista De Neurologia|February 23, 2011
[Review of the novelties presented at the 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II)]O Fernandez-Fernandez, J C Alvarez-Cermeno, T Arbizu-Urdiain, et al.
Pageof 102

Showing results (981-990 of 1,020) with videos related to

Sort By:
Pageof 102
ESMO Open|April 11, 2022
Results from the INMUNOSUN-SOGUG trial: a prospective phase II study of sunitinib as a second-line therapy in patients with metastatic renal cell carcinoma after immune checkpoint-based combination therapyE Grande, T Alonso-Gordoa, O Reig, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 9, 2010
Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE)R Garcia-Carbonero, J Capdevila, G Crespo-Herrero, et al.
Journal of Nutritional Science|October 29, 2019
Association between adiposity levels and cognitive impairment in the Chilean older adult populationY Concha-Cisternas, F Lanuza, H Waddell, et al.
Journal of Medicinal Chemistry|July 20, 1999
Identification of pharmacokinetically stable 3, 10-dibromo-8-chlorobenzocycloheptapyridine farnesyl protein transferase inhibitors with potent enzyme and cellular activitiesA G Taveras, J Deskus, J Chao, et al.
BMC Musculoskeletal Disorders|February 17, 2012
Land- and water-based exercise intervention in women with fibromyalgia: the al-Andalus physical activity randomised controlled trialAna Carbonell-Baeza, Jonatan R Ruiz, Virginia A Aparicio, et al.
Clinical Rheumatology|November 27, 2014
Work disability is related to the presence of arthritis and not to a specific diagnosis. Results from a large early arthritis cohort in ArgentinaGustavo Citera, Hernan Maldonado Ficco, Rodolfo S Pérez Alamino, et al.
Bioorganic & Medicinal Chemistry|January 1, 1997
Antitumor 8-chlorobenzocycloheptapyridines: a new class of selective, nonpeptidic, nonsulfhydryl inhibitors of ras farnesylationA K Mallams, F G Njoroge, R J Doll, et al.
Allergologia Et Immunopathologia|January 1, 2019
Treatment, outcomes and costs of asthma exacerbations in Chilean children: a prospective multicenter observational studyA M Herrera, P Brand, G Cavada, et al.
Revista De Neurologia|February 12, 2011
[Review of the novelties presented at the 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I)]Oscar Fernández-Fernández, José C Alvarez-Cermeño, Txomin Arbizu-Urdiain, et al.
Revista De Neurologia|February 23, 2011
[Review of the novelties presented at the 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II)]O Fernandez-Fernandez, J C Alvarez-Cermeno, T Arbizu-Urdiain, et al.
Pageof 102